Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 May;11(1):1–11.

T and B lymphocytes in New Zealand Black mice: an analysis of the theta, TL and MBLA markers

B H Waksman, M C Raff, June East
PMCID: PMC1553685  PMID: 4402642

Abstract

The lymphocytes of thymus, blood, spleen, lymph nodes and bone marrow were studied in NZB mice between the ages of 1 and 14 months, and compared with lymphocytes of A and CBA strain mice of the same age. By standard cytotoxicity techniques, the proportion of cells possessing the θ, TL and MBLA markers was found to be similar in NZB in mice and controls. In 14-month old NZBs, whose spleen was largely replaced by reticulum cell sarcoma, and in younger recipients of the passaged tumour, there was a reduction in the percentage of θ and MBLA-positive cells in the spleen. In a few mice at 4 and 9 months, small numbers of MBLA-positive cells were present in the thymus and there was a corresponding decrease in θ-positive cells. TL-positive cells were not present outside the thymus, and θ-positive cells were not present in the bone marrow in unusual numbers. NZB peripheral lymphocytes appeared to have the same surface concentration of θ as those of A or CBA mice, as judged by anti-θ titration curves. The reticulum cell sarcoma was shown to be θ-negative and MBLA-negative, while an NZB thymoma was θ-positive, TL-positive and MBLA-negative. It was concluded that the peripheral lymphoid organs contain a large population of T lymphocytes of abnormal character.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. Y., Gleichmann E., Gleichmann H., Beldotti L., Andre-Schwartz J., Schwartz R. S. Chronic allogeneic disease. II. Development of lymphomas. J Exp Med. 1970 Sep 1;132(3):417–439. doi: 10.1084/jem.132.3.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BLAESE R. M., MARTINEZ C., GOOD R. A. IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS. J Exp Med. 1964 Feb 1;119:211–224. doi: 10.1084/jem.119.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cantor H., Asofsky R. Synergy among lymphoid cells mediating the graft-versus-host response. II. Synergy in graft-versus-host reactions produced by Balb-c lymphoid cells of differing anatomic origin. J Exp Med. 1970 Feb;131(2):235–246. doi: 10.1084/jem.131.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cantor H., Asofsky R., Talal N. Synergy among lymphoid cells mediating the graft-versus-host response. I. Synergy in graft-versus-host reactions produced by cells from NZB-Bl mice. J Exp Med. 1970 Feb;131(2):223–234. doi: 10.1084/jem.131.2.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cerottini J. C., Lambert P. H., Dixon F. J. Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med. 1969 Nov 1;130(5):1093–1105. doi: 10.1084/jem.130.5.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen A., Schlesinger M. Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation. 1970 Jul;10(1):130–132. doi: 10.1097/00007890-197007000-00027. [DOI] [PubMed] [Google Scholar]
  7. Cole L. J., Nowell P. C. Parental-F1 hybrid bone marrow chimeras: high incidence of donor-type lymphomas. Proc Soc Exp Biol Med. 1970 Jul;134(3):653–657. doi: 10.3181/00379727-134-34854. [DOI] [PubMed] [Google Scholar]
  8. Denman A. M., Denman E. J. Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol. 1970 Apr;6(4):457–472. [PMC free article] [PubMed] [Google Scholar]
  9. Denman A. M., Denman E. J., Holborow E. J. Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet. 1967 May 20;1(7499):1084–1086. doi: 10.1016/s0140-6736(67)92653-0. [DOI] [PubMed] [Google Scholar]
  10. Diener E. The immune response in NZB and NZB x C3H F1-hybrid mice as measured by the haemolysin plaque technique. Int Arch Allergy Appl Immunol. 1966;30(2):120–131. doi: 10.1159/000229801. [DOI] [PubMed] [Google Scholar]
  11. East J. Immunopathology and neoplasms in New Zealand black (NZB) and SJL-J mice. Prog Exp Tumor Res. 1970;13:84–134. doi: 10.1159/000386038. [DOI] [PubMed] [Google Scholar]
  12. Halpern B., Fray A. Déclenchement de l'anémie hémolytique autoimmune chez de jeunes souriceaux NZB par l'administration de Corynebacterium parvum. Ann Inst Pasteur (Paris) 1969 Dec;117(6):778–789. [PubMed] [Google Scholar]
  13. Howie J. B., Helyer B. J. Autoimmune disease in mice. Ann N Y Acad Sci. 1965 Jun 30;124(1):167–177. doi: 10.1111/j.1749-6632.1965.tb18955.x. [DOI] [PubMed] [Google Scholar]
  14. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  15. Katz D. H., Paul W. E., Goidl E. A., Benacerraf B. Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med. 1971 Feb 1;133(2):169–186. doi: 10.1084/jem.133.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leventhal B. G., Talal N. Response of NZB and NZB-NZW spleen cells to mitogenic agents. J Immunol. 1970 Apr;104(4):918–923. [PubMed] [Google Scholar]
  18. Mellors R. C. Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids. Int Rev Exp Pathol. 1966;5:217–252. [PubMed] [Google Scholar]
  19. Playfair J. H., Krsiakova M. Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation. 1969 May;7(5):443–444. doi: 10.1097/00007890-196905000-00029. [DOI] [PubMed] [Google Scholar]
  20. Playfair J. H. Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology. 1968 Jul;15(1):35–50. [PMC free article] [PubMed] [Google Scholar]
  21. Raff M. C., Nase S., Mitchison N. A. Mouse specific bone marrow-derived lymphocyte antigen as a marker for thymus-independent lymphocytes. Nature. 1971 Mar 5;230(5288):50–51. doi: 10.1038/230050a0. [DOI] [PubMed] [Google Scholar]
  22. Raff M. C., Owen J. J. Thymus-derived lymphocytes: their distribution and role in the development of peripheral lymphoid tissues of the mouse. Eur J Immunol. 1971 Jan;1(1):27–30. doi: 10.1002/eji.1830010105. [DOI] [PubMed] [Google Scholar]
  23. Raff M. C. Surface antigenic markers for distinguishing T and B lymphocytes in mice. Transplant Rev. 1971;6:52–80. doi: 10.1111/j.1600-065x.1971.tb00459.x. [DOI] [PubMed] [Google Scholar]
  24. Raff M. C., Wortis H. H. Thymus dependence of theta-bearing cells in the peripheral lymphoid tissues of mice. Immunology. 1970 Jun;18(6):931–942. [PMC free article] [PubMed] [Google Scholar]
  25. Raff M. Theta isoantigen as a marker of thymus-derived lymphocytes in mice. Nature. 1969 Oct 25;224(5217):378–379. doi: 10.1038/224378a0. [DOI] [PubMed] [Google Scholar]
  26. Russell A. S., Denman A. M. Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol. 1969 Sep;5(3):265–272. [PMC free article] [PubMed] [Google Scholar]
  27. Staples P. J., Steinberg A. D., Talal N. Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med. 1970 Jun 1;131(6):1223–1238. doi: 10.1084/jem.131.6.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Staples P. J., Talal N. Impaired recovery of plaque-forming cells in New Zealand mice given cyclophosphamide. J Immunol. 1970 May;104(5):1101–1107. [PubMed] [Google Scholar]
  29. Staples P. J., Talal N. Rapid loss of tolerance induced in weanling NZB and B-W F1 mice. Science. 1969 Mar 14;163(3872):1215–1216. doi: 10.1126/science.163.3872.1215. [DOI] [PubMed] [Google Scholar]
  30. Staples P. J., Talal N. Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med. 1969 Jan 1;129(1):123–139. doi: 10.1084/jem.129.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Steinberg A. D., Baron S., Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1102–1107. doi: 10.1073/pnas.63.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stutman O., Yunis E. J., Good R. A. Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med. 1968 Apr;127(4):1204–1207. doi: 10.3181/00379727-127-32910. [DOI] [PubMed] [Google Scholar]
  33. Weir D. M., McBride W., Naysmith J. D. Immune response to a soluble protein antigen in NZB mice. Nature. 1968 Sep 21;219(5160):1276–1277. doi: 10.1038/2191276a0. [DOI] [PubMed] [Google Scholar]
  34. Zatz M. M., Mellors R. C., Lance E. M. Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol. 1971 Mar;8(3):491–500. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES